NCT01927822

Brief Summary

This study aims to analyze the factors influencing the abortion interval of second-trimester termination of pregnancy using misoprostol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

August 18, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 23, 2013

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
Last Updated

July 7, 2015

Status Verified

July 1, 2015

Enrollment Period

1 year

First QC Date

August 18, 2013

Last Update Submit

July 4, 2015

Conditions

Labor Induction

Keywords

termination of pregnancy, abortion

Outcome Measures

Primary Outcomes (1)

  • Successful termination rate by Cytotec.

    1 week

Secondary Outcomes (1)

  • Factors affecting abortion interval by cytotec.

    1 week

Study Arms (1)

Pregnancy

Women who underwent termination of pregnancy at second trimester due to a variety of causes

Eligibility Criteria

Age13 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

This is a single-center, retrospective chart review study. All female patients who were admitted for medical termination of second-trimester pregnancy from January 2008 to May 2013, at the Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital were recruited.

You may qualify if:

  • All female patients who were admitted for medical termination of second-trimester pregnancy

You may not qualify if:

  • \. Patients who are allergy to Cytotec.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Far Eastern Memorial Hospital

New Taipei, Taiwan, 220, Taiwan

Location

Study Officials

  • Sheng-Mou Hsiao, MD

    Far Eastern Memorial Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Department of Obstetrics & Gynecology

Study Record Dates

First Submitted

August 18, 2013

First Posted

August 23, 2013

Study Start

August 1, 2013

Primary Completion

August 1, 2014

Study Completion

August 1, 2014

Last Updated

July 7, 2015

Record last verified: 2015-07

Locations

TW(1)